ABCELLERA BIOLOGICS (8QQ) — Defensive Interval Ratio
ABCELLERA BIOLOGICS (8QQ) has a Defensive Interval Ratio of 2631 days as of December 2025. Defensive assets of €463.61 Million (cash €-, short-term investments €405.31 Million, receivables €58.29 Million) cover 2631 days of daily cash needs of €176.18K/day. Check 8QQ tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
ABCELLERA BIOLOGICS Defensive Interval Ratio (2021–2025)
This chart shows how ABCELLERA BIOLOGICS's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 2631 days, meaning defensive assets of €463.61 Million can fund 2631 days of operations without new revenue. Also explore 8QQ year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for ABCELLERA BIOLOGICS (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for ABCELLERA BIOLOGICS from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see ABCELLERA BIOLOGICS (8QQ) market capitalisation.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2631 days | €463.61 Million | €176.18K/day | €- | €405.31 Million | ▲ +235 days |
| 2024 | 2396 days | €502.90 Million | €209.90K/day | €- | €469.29 Million | ▲ +378 days |
| 2023 | 2018 days | €657.86 Million | €326.06K/day | €- | €627.26 Million | ▲ +356 days |
| 2022 | 1661 days | €538.54 Million | €324.16K/day | €- | €499.95 Million | ▲ +429 days |
| 2021 | 1232 days | €407.41 Million | €330.62K/day | €- | €246.84 Million | — |